191 related articles for article (PubMed ID: 34568031)
1. Construction of Novel Methylation-Driven Gene Model and Investigation of PARVB Function in Glioblastoma.
Yu W; Wu P; Wang F; Miao L; Han B; Jiang Z
Front Oncol; 2021; 11():705547. PubMed ID: 34568031
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Novel DNA Methylation-Driven Gene Based Molecular Classification and Predictive Model for Overall Survival and Immunotherapy Response in Patients With Glioblastoma: A Multiomic Analysis.
Wang Z; Gao L; Guo X; Lian W; Deng K; Xing B
Front Cell Dev Biol; 2020; 8():576996. PubMed ID: 33015072
[TBL] [Abstract][Full Text] [Related]
3. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.
Liu J; Ji C; Wang Y; Zhang C; Zhu H
Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261
[TBL] [Abstract][Full Text] [Related]
4. Identification of
Xia M; Tong S; Gao L
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255198
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
[TBL] [Abstract][Full Text] [Related]
6. Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
Lv L; Cao L; Hu G; Shen Q; Wu J
Front Genet; 2020; 11():294. PubMed ID: 32296463
[TBL] [Abstract][Full Text] [Related]
7. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
8. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
9. Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Front Oncol; 2020; 10():1257. PubMed ID: 32793502
[No Abstract] [Full Text] [Related]
10. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
Bi Y; Wu ZH; Cao F
BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
[TBL] [Abstract][Full Text] [Related]
11. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
Sun R; Pan Y; Mu L; Ma Y; Shen H; Long Y
Front Genet; 2021; 12():768930. PubMed ID: 34733320
[No Abstract] [Full Text] [Related]
12. IKBIP might be a potential prognostic biomarker for glioblastoma multiforme.
Chen H; Liang B; Luo X; Zhang W; Song X; Lan H; Yue Q; Xie J; Zhang M
Int Immunopharmacol; 2023 May; 118():110030. PubMed ID: 36989893
[TBL] [Abstract][Full Text] [Related]
13. Co-expression prognostic-related genes signature base on propofol and sevoflurane anesthesia predict prognosis and immunotherapy response in glioblastoma.
Hou Z; Luo D; Luo H; Hui Q; Xu Y; Lin X; Xu Z
Ann Med; 2023 Dec; 55(1):778-792. PubMed ID: 36856519
[TBL] [Abstract][Full Text] [Related]
14. A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM.
Cheng Q; Huang C; Cao H; Lin J; Gong X; Li J; Chen Y; Tian Z; Fang Z; Huang J
Front Genet; 2019; 10():906. PubMed ID: 31632439
[No Abstract] [Full Text] [Related]
15. Comprehensive
Wang Z; Ji X; Gao L; Guo X; Lian W; Deng K; Xing B
Front Oncol; 2021; 11():553594. PubMed ID: 33747903
[TBL] [Abstract][Full Text] [Related]
16. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
Front Immunol; 2021; 12():706936. PubMed ID: 34899682
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis.
He Z; Wang C; Xue H; Zhao R; Li G
Front Oncol; 2020; 10():1631. PubMed ID: 33042807
[TBL] [Abstract][Full Text] [Related]
19. A novel methylation signature predicts radiotherapy sensitivity in glioma.
Feng Y; Li G; Shi Z; Yan X; Wang Z; Jiang H; Chen Y; Li R; Zhai Y; Chang Y; Zhang W; Yuan F
Sci Rep; 2020 Nov; 10(1):20406. PubMed ID: 33230136
[TBL] [Abstract][Full Text] [Related]
20. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
Front Genet; 2020; 11():253. PubMed ID: 32296458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
